BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22414960)

  • 1. The role of Nogo-A in neuroregeneration: a review.
    Wang T; Xiong JQ; Ren XB; Sun W
    Brain Res Bull; 2012 Apr; 87(6):499-503. PubMed ID: 22414960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nogo and axon regeneration.
    Schwab ME
    Curr Opin Neurobiol; 2004 Feb; 14(1):118-24. PubMed ID: 15018947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogos and the Nogo-66 receptor: factors inhibiting CNS neuron regeneration.
    Ng CE; Tang BL
    J Neurosci Res; 2002 Mar; 67(5):559-65. PubMed ID: 11891768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nogo: a molecular determinant of axonal growth and regeneration.
    Grandpré T; Strittmatter SM
    Neuroscientist; 2001 Oct; 7(5):377-86. PubMed ID: 11597097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury.
    Walmsley AR; Mir AK
    Curr Pharm Des; 2007; 13(24):2470-84. PubMed ID: 17692015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nogo-A functions during the development of the central nervous system and in the adult].
    Mingorance A; Soriano-García E; del Rio JA
    Rev Neurol; 2004 Sep 1-15; 39(5):440-6. PubMed ID: 15378458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q; Cai W; Li S; Zhang Y; Su B
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nogo-A, a potent inhibitor of neurite outgrowth and regeneration.
    Huber AB; Schwab ME
    Biol Chem; 2000; 381(5-6):407-19. PubMed ID: 10937871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and neurotrophic factors fail to affect Nogo-A mRNA expression in differentiated human neurones: implications for inflammation-related axonal regeneration in the central nervous system.
    Satoh JI; Kuroda Y
    Neuropathol Appl Neurobiol; 2002 Apr; 28(2):95-106. PubMed ID: 11972796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T; Li S; Strittmatter SM
    Nature; 2002 May; 417(6888):547-51. PubMed ID: 12037567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein.
    GrandPré T; Nakamura F; Vartanian T; Strittmatter SM
    Nature; 2000 Jan; 403(6768):439-44. PubMed ID: 10667797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
    Chen MS; Huber AB; van der Haar ME; Frank M; Schnell L; Spillmann AA; Christ F; Schwab ME
    Nature; 2000 Jan; 403(6768):434-9. PubMed ID: 10667796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of the human Nogo-A functional domains. Solution structure of Nogo-40, a Nogo-66 receptor antagonist enhancing injured spinal cord regeneration.
    Li M; Shi J; Wei Z; Teng FY; Tang BL; Song J
    Eur J Biochem; 2004 Sep; 271(17):3512-22. PubMed ID: 15317586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.